| DNA–drug conjugates enable logic-gated drug delivery amplified by hybridization chain reactions | Nature biotechnology |  | | 2026 | 5 | 11 |
|
| Discovery of a Reversible Sub‐Picomolar Thrombin Inhibitor Using DCC | Angewandte Chemie | | | 2026 | 1 | 1 |
|
| Peptides on Tap: Automated Flow Synthesis With Standard HPLC | Helvetica chimica acta | | | 2026 | 1 | 1 |
|
| DNA-Drug Conjugates (DDCs) for computed delivery | | | | 2025 | 44 | 48 |
|
| Darwinian Evolution and Self-Assembly of Synthetic Molecules for Next-Generation Therapeutics | |  | | 2025 | 136 | 1 |
|
| PTPRZ1-targeting RNA CAR T cells exert antigen-specific and bystander antitumor activity in glioblastoma | Cancer immunology research | | | 2024 | 305 | 338 |
|
| Reversible Anticoagulants: Inspired by Nature, Designed for Safety | TheScienceBreaker | | | 2024 | 28 | 30 |
|
| Translation of Deoxyribonucleic Acid into Synthetic Alpha Helical Peptides for Darwinian Evolution | JACS Au | | | 2024 | 34 | 40 |
|
| Development of supramolecular anticoagulants with on-demand reversibility | Nature biotechnology | | | 2024 | 204 | 296 |
|
| PTPRZ1-targeting RNA CAR-T cells exert antigen-specific and bystander antitumor activity in glioblastoma | | | | 2023 | 247 | 771 |
|
| A mating mechanism to generate diversity for the Darwinian selection of DNA-encoded synthetic molecules | Nature chemistry |  | | 2022 | 328 | 0 |
|
| DNA‐Encoded Libraries: Towards Harnessing their Full Power with Darwinian Evolution | Angewandte Chemie | | | 2022 | 181 | 470 |
|
